News

Latest Releases

U.S. Senator Tina Smith Celebrates U.S. Trade Mission to Colombia

WASHINGTON, D.C. – U.S. Senator Tina Smith (D-MN) celebrated Lamex Food, Inc.’s participation in a trade mission to Bogota, Colombia, led by the United States Department of Agriculture (USDA) to expand foreign market access for American agricultural products. The Bloomington, MN based food group is one of 23 businesses and organizations who joined the trip from August 13-15 with USDA Under Secretary Alexis M. Taylor to discuss policy and business partnerships that will boost American agricultural exports to Colombia. “Agricultural exports support farming in Minnesota and provide economic benefits to the state,” said Sen. Smith.“This trade mission is a great opportunity to expand market access for American goods in Colombia, and for Lamex Food to create new business partnerships overseas.” Senator Smith, a member of the Senate Agriculture Committee, has been a strong advocate for expanding agricultural market access globally. Earlier this year, she supported a USDA trade mission to India focused on Indigenous food products. ###

U.S. Senators Amy Klobuchar, Tina Smith Announce Funding to Help Grow Global Export Markets for Minnesota Producers

MINNEAPOLIS – U.S. Senators Amy Klobuchar and Tina Smith (both D-MN) announced funding from the Regional Agricultural Promotion Program (RAPP) to help grow export markets for American farm and food products around the world. The additional $300 million investment will go to organizations across the U.S. to implement market development projects focusing on a wide range of products and agricultural markets. “Boosting America’s agricultural exports is great for Minnesota farmers and rural economies,” said Klobuchar. “This funding will help farmers enter the global export market and maintain America’s leadership in agricultural exports.” “Minnesota has long been a linchpin in America’s agricultural market, and I’m proud to advocate for projects that enable farmers in Minnesota to expand their production and stay competitive in the global market,” said Senator Smith. “This investment will help to expand our export policies worldwide, allowing farmers in Minnesota to establish, build, and maintain their partnerships in international markets.” Secretary of the Department of Agriculture (USDA) Tom Vilsack announced in October 2023 that USDA would establish RAPP to help U.S. exporters expand their customer base beyond markets such as China, Mexico and Canada, which account for nearly half of all current exports. In this round of funding, USDA is allocating $25 million specifically for Africa, which has the some of the fastest-growing economies in the world. For more information about RAPP and how to apply, click here. Applications are due on October 4, 2024. ###

U.S. Senator Tina Smith’s Statement on the Vote to Confirm of Justice Ketanji Brown Jackson

WASHINGTON, D.C. [04/07/22]—Today, U.S. Senator Tina Smith (D-Minn.) released the following statement on the bipartisan confirmation of Justice Ketanji Brown Jackson to the Supreme Court of the United States: “I had a front row seat to history today as the Senate voted to confirm Judge Ketanji Brown Jackson to the Supreme Court. “I was proud to vote to confirm Judge Jackson, the first Black woman and first former federal public defender to serve on the Supreme Court. Judge Jackson showed character, intellect, and grace through the entire confirmation process. She is a brilliant legal mind and has stellar credentials as

Sens. Smith, Stabenow, and Rep. Maloney Lead Colleagues in Introducing Bicameral Package of Legislation to Target Abusive Pharmaceutical Business Practices

Washington, D.C. [04.07.22]—Today, Sens. Tins Smith (D-MN), Debbie Stabenow (D-MI), and Rep. Carolyn B. Maloney (D-NY-12), led colleagues—including Rep. Peter Welch and Rep. Jan Schakowsky—in introducing a package of legislation targeting business practices pharmaceutical companies use to suppress competition, maintain market monopolies, and keep drug prices high. The legislative reforms follow the Oversight Committee’s three-year investigation into pharmaceutical pricing and business practices that exposed pharmaceutical company practices to suppress competition from lower-priced generics and biosimilars and make drug prices unaffordable for many Americans.  “There is no good reason Americans should be paying more than any country in the world for

Sens. Smith, Stabenow, and Rep. Maloney Lead Colleagues in Introducing Bicameral Package of Legislation to Target Abusive Pharmaceutical Business Practices

Washington, D.C. [04.07.22]—Today, Sens. Tins Smith (D-MN), Debbie Stabenow (D-MI), and Rep. Carolyn B. Maloney (D-NY-12), led colleagues—including Rep. Peter Welch and Rep. Jan Schakowsky—in introducing a package of legislation targeting business practices pharmaceutical companies use to suppress competition, maintain market monopolies, and keep drug prices high. The legislative reforms follow the Oversight Committee’s three-year investigation into pharmaceutical pricing and business practices that exposed pharmaceutical company practices to suppress competition from lower-priced generics and biosimilars and make drug prices unaffordable for many Americans.  “There is no good reason Americans should be paying more than any country in the world for

Klobuchar, Smith Secure Significant Federal Funding to Expand College Access for American Indian and Alaska Native Students

WASHINGTON – U.S. Senators Amy Klobuchar (D-MN) and Tina Smith (D-MN) secured $500,000 in federal funding to expand a program at Saint Paul College focused on providing academic and social support to American Indian and Alaska Native students.  Specifically, the funding will help grow the Four Directions Pathway program at Saint Paul College. The program is designed to promote college access and success for American Indian and Alaska Native (AI/AN) students through a culturally relevant lens. In 2020, AI/AN communities in Minnesota saw a degree attainment rate of 27.5%, a figure well below the state’s 70% attainment goal. Improving access to

en_USEnglish